Showing 31-40 of 7110 results for "".
Pearls for Treating Skin Cancer
https://practicaldermatology.com/topics/general-topics/pearls-for-treating-skin-cancer/18446/When should you treat basal cell carcinomas with adjuvant therapies before excising? Why is the number two important to remember when treating squamous cell carcinoma? Is Merkel cell carcinoma on the rise? Gary Goldenberg, MD answers these questions and offers an update on the newest therapies and b"Ask Me Anything" Mentorship Session With Dr. DiAnne Davis
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-dianne-davis/39879/DiAnne Davis, MD, FAAD, discusses her career journey as a board-certified, fellowship trained cosmetic dermatologist with expertise in skin of color, laser and light-based procedures, neuromodulators, injectable fillers, platelet rich plasma (PRP), sclerotherapy, body contouring, acne scars, laser bPsoriasis Treatment in 2025: More Options, Better Outcomes
https://practicaldermatology.com/issues/august-2025/psoriasis-treatment-in-2025-more-options-better-outcomes/36706/We have better drugs to treat psoriasis than almost any other dermatologic disease state. For patients, it is an excellent time to have psoriasis.Is Irritable Bowel Linked to Irritable Skin?
https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/Exploring irritable bowel syndrome’s link to dermatologic conditions.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Scientifically Speaking: Applying Energy-Based Devices Across Skin Tones
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-applying-energy-based-devices-across-skin-tones/19895/With advancements in technology and a patient-focused approach to treatment, it's possible to safely and effectively apply energy-based devices to a range of skin concerns in patients with darker skin. Host Joel L. Cohen, MD discusses treatment strategies for melasma, acne, PFB, scarring and more wiBasal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.The Inside Scoop on Cosmeceuticals: From Top to Bottom
https://practicaldermatology.com/topics/general-topics/the-inside-scoop-on-cosmeceuticals-from-top-to-bottom/20896/Top derms dish about their favorite cosmeceuticals, including options beyond wrinkle fighting.Fringe Benefit Plans: Valuable Planning Tools You Haven't Heard Of
https://practicaldermatology.com/topics/practice-management/fringe-benefit-plans-valuable-planning-tools-you-havent-heard-of/21488/Fringe benefit plans lack many of the restrictions of qualified plans and, therefore, are relatively inexpensive to implement.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended surviv